BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21596604)

  • 1. Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection.
    Musgrave CR; Bookstaver PB; Sutton SS; Miller AD
    Int J Infect Dis; 2011 Jul; 15(7):e438-48. PubMed ID: 21596604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Clostridium difficile-associated disease: old therapies and new strategies.
    Aslam S; Hamill RJ; Musher DM
    Lancet Infect Dis; 2005 Sep; 5(9):549-57. PubMed ID: 16122678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative therapies for Clostridium difficile infections.
    Venuto C; Butler M; Ashley ED; Brown J
    Pharmacotherapy; 2010 Dec; 30(12):1266-78. PubMed ID: 21114394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile and the disease it causes.
    Norén T
    Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Past, present, and future therapies for Clostridium difficile-associated disease.
    Surowiec D; Kuyumjian AG; Wynd MA; Cicogna CE
    Ann Pharmacother; 2006 Dec; 40(12):2155-63. PubMed ID: 17148650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and opportunities in the management of Clostridium difficile infection.
    DuPont HL
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):863-74. PubMed ID: 25012255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future treatment modalities for Clostridium difficile-associated disease.
    Halsey J
    Am J Health Syst Pharm; 2008 Apr; 65(8):705-15. PubMed ID: 18387898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent Clostridium difficile infection: causality and therapeutic approaches.
    Johnson S
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S33-6. PubMed ID: 19303567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile colitis.
    Efron PA; Mazuski JE
    Surg Clin North Am; 2009 Apr; 89(2):483-500, x. PubMed ID: 19281896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative strategies for Clostridium difficile infection.
    Bauer MP; van Dissel JT
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S51-6. PubMed ID: 19303571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of Clostridium difficile infection.
    Dupont HL
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New treatment options for infections with Clostridium difficile].
    van Nood E; Keller JJ; Kuijper EJ; Speelman P
    Ned Tijdschr Geneeskd; 2013; 157(48):A6580. PubMed ID: 24279951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
    Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
    J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clostridium difficile infection: epidemiology, disease burden and therapy].
    Gulácsi L; Kertész A; Kopcsóné Németh I; Banai J; Ludwig E; Prinz G; Reményi P; Strbák B; Zsoldiné Urbán E; Baji P; Péntek M; Brodszky V
    Orv Hetil; 2013 Jul; 154(30):1188-93. PubMed ID: 23876616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Clostridium difficile Infection With Probiotics.
    Evans CT; Johnson S
    Clin Infect Dis; 2015 May; 60 Suppl 2():S122-8. PubMed ID: 25922397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile: an update for the primary care clinician.
    Salkind AR
    South Med J; 2010 Sep; 103(9):896-902. PubMed ID: 20697321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fidaxomicin versus vancomycin for Clostridium difficile infection.
    Louie TJ; Miller MA; Mullane KM; Weiss K; Lentnek A; Golan Y; Gorbach S; Sears P; Shue YK;
    N Engl J Med; 2011 Feb; 364(5):422-31. PubMed ID: 21288078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile Colitis Prevention and Treatment.
    Dinleyici M; Vandenplas Y
    Adv Exp Med Biol; 2019; 1125():139-146. PubMed ID: 30689174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.